News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Refuses to Disclose Tamiflu Data: Scientists


1/17/2012 8:31:50 AM

An influential review that is due out tomorrow will not contain up-to-date efficacy information about Tamiflu, the widely used influenza drug sold by Roche, because researchers at the Cochrane Collaboration say they were stymied by the drugmaker in their efforts to fully assess the medication, according to reports. Iain Chalmers, one of the founders of the Cochrane Collaboration, a non-profit group dedicated to analyzing medical evidence, last week told a conference on research integrity in London that a review of influenza treatments will state that Roche would not comply with requests to provide additional data, Nature writes.

Read at Pharmalot
Read at Nature
Read at Independent


comments powered by Disqus
Roche
 
 
Influenza

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES